Implications of the 2014 Androgen Excess and Polycystic Ovary Syndrome Society guidelines on polycystic ovarian morphology for polycystic ovary syndrome diagnosis

被引:9
|
作者
Christ, J. P. [1 ,2 ]
Gunning, M. N. [2 ]
Fauser, B. C. J. M. [2 ]
机构
[1] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Univ Med Ctr Utrecht, Dept Reprod Med, Utrecht, Netherlands
关键词
Diagnostic criteria; Follicle number; Hyperandrogenism; Metabolism; Polycystic ovaries; Ultrasound; ROTTERDAM;
D O I
10.1016/j.rbmo.2017.06.020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The Androgen Excess and Polycystic Ovary Syndrome Society (AEPCOS) has recommended an updated threshold for polycystic ovarian morphology (PCOM) of 25 follicles or more, 10 ml or more of ovarian volume, or both. We describe the effect of these guidelines on reproductive and metabolic characteristics in 404 women. These women were separated into four groups: group A: hyperandrogenism and oligo-amenorrhoea (n = 157); group B: hyperandrogenism or oligo-amenorrhoea and PCOM meeting AEPCOS 2014 criteria (n = 125); group C: hyperandrogenism or oligo-amenorrhoea and PCOM meeting Rotterdam 2003 but not AEPCOS 2014 criteria (n = 72); and group D: non-PCOS not meeting either criteria (n = 50). Groups B, C and D did not differ across any metabolic markers. The AEPCOS 2014 guidelines may have limited utility in distinguishing metabolic risk factors and result in the exclusion of a large group of oligo-anovulatory women. (C) 2017 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:480 / 483
页数:4
相关论文
共 50 条
  • [1] Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society
    Moran, Lisa J.
    Pasquali, Renato
    Teede, Helena J.
    Hoeger, Kathleen M.
    Norman, Robert J.
    [J]. FERTILITY AND STERILITY, 2009, 92 (06) : 1966 - 1982
  • [2] Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
    Dewailly, Didier
    Lujan, Marla E.
    Carmina, Enrico
    Cedars, Marcelle I.
    Laven, Joop
    Norman, Robert J.
    Escobar-Morreale, Hector F.
    [J]. HUMAN REPRODUCTION UPDATE, 2014, 20 (03) : 334 - 352
  • [3] Androgen excess: a hallmark of polycystic ovary syndrome
    Wang, Kexin
    Li, Yanhua
    Chen, Yu
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Adrenal androgen excess in the polycystic ovary syndrome
    Azziz, R
    [J]. ENDOCRINOLOGIST, 2000, 10 (04): : 245 - 254
  • [5] The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum
    Rosenfield, Robert L.
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2015, 28 (06) : 412 - 419
  • [6] Polycystic ovary syndrome, androgen excess, and the impact on bone
    Zborowski, JV
    Talbott, EO
    Cauley, JA
    [J]. OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2001, 28 (01) : 135 - +
  • [7] Androgen excess is the key element in polycystic ovary syndrome
    Azziz, R
    [J]. FERTILITY AND STERILITY, 2003, 80 (02) : 252 - 254
  • [8] Targets to treat androgen excess in polycystic ovary syndrome
    Luque-Ramirez, Manuel
    Francisco Escobar-Morreale, Hector
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (11) : 1545 - 1560
  • [9] Polycystic Ovary Syndrome and the Neuroendocrine Consequences of Androgen Excess
    Silva, Mauro S. B.
    Campbell, Rebecca E.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2022, 12 (02) : 3347 - 3369
  • [10] Criteria for Polycystic Ovarian Morphology in Polycystic Ovary Syndrome as a Function of Age
    Alsamarai, S.
    Adams, J. M.
    Murphy, M. K.
    Post, M. D.
    Hayden, D. L.
    Hall, J. E.
    Welt, C. K.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (12): : 4961 - 4970